PX1 Research supplies USA-manufactured, high-purity Gonadorelin formulated strictly for in vitro laboratory research and preclinical experimental models. Every lot undergoes rigorous analytical validation—including RP-HPLC purity assessment, mass spectrometry identity verification, and endotoxin quantification—to ensure reliable, reproducible data for institutional investigators.
PX1 Research supplies USA-manufactured, high-purity Gonadorelin formulated strictly for in vitro laboratory research and preclinical experimental models. Every lot undergoes rigorous analytical validation—including RP-HPLC purity assessment, mass spectrometry identity verification, and endotoxin quantification—to ensure reliable, reproducible data for institutional investigators.
When purchasing researchers seek to buy gonadorelin for sale online, securing verified analytical purity and documented lot traceability is critical for experimental integrity. Research-grade Gonadorelin is a synthetic decapeptide identical in sequence to native endogenous Gonadotropin-Releasing Hormone (GnRH), utilized in laboratory settings to investigate pituitary receptor binding, neuroendocrine signaling cascades, and gonadotropin release kinetics.
PX1 Research provides laboratory-grade Gonadorelin synthesized in USA-based, GMP-compliant facilities. Each order includes a lot-specific Certificate of Analysis (COA) generated by an independent ISO 17025 accredited laboratory, confirming peptide purity exceeding 99% via High-Performance Liquid Chromatography (HPLC) and mass identity through Electrospray Ionization Mass Spectrometry (ESI-MS). Principal investigators can review full chemical specifications across our catalog of all peptides before procuring material for cellular or animal model experiments.
Gonadorelin is a pyroglutamyl decapeptide with the primary amino acid sequence Pyroglutamyl-Histidyl-Tryptophyl-Seryl-Tyrosyl-Glycyl-Leucyl-Arginyl-Prolyl-Glycinamide (pE-H-W-S-Y-G-L-R-P-G-NH2). With a molecular formula of C55H75N17O13 and a theoretical monoisotopic mass of approximately 1182.3 Daltons, the peptide features an N-terminal pyroglutamic acid residue and a C-terminal glycinamide modification that preserve enzymatic resistance against primary aminopeptidases and carboxypeptidases in cell culture media.
In academic and pharmaceutical research, synthetic Gonadorelin acts as a full agonist at the Gonadotropin-Releasing Hormone Receptor (GnRHR), a seven-transmembrane G-protein-coupled receptor (GPCR). The molecular conformation of Gonadorelin allows high-affinity binding to the extracellular domain of GnRHR, initiating intracellular signal transduction pathways via the Gq/11 protein subunit. Understanding the specific structural integrity of this decapeptide is essential when designing baseline receptor binding and displacement assays in our dedicated research hub.
Preclinical studies indicate that Gonadorelin plays a central role in modulating the hypothalamic-pituitary-gonadal (HPG) axis. Upon binding to the GnRH receptor on gonadotrope cells in the anterior pituitary, Gonadorelin stimulates phospholipase C (PLC), driving the cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers rapid intracellular calcium release from the endoplasmic reticulum, while DAG activates protein kinase C (PKC).
This dual intracellular pathway mediates the transcription and exocytosis of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). In vitro assays demonstrate that the pattern of Gonadorelin administration alters receptor dynamics significantly: pulsatile exposure maintains receptor sensitivity and sustained LH/FSH secretion, whereas continuous, high-concentration exposure causes rapid receptor internalization, microaggregation, and down-regulation (desensitization). Researchers studying receptor desensitization models rely on high-purity compounds to accurately delineate these kinetic shifts.
When designing neuroendocrine or reproductive biochemistry protocols, investigators frequently compare native-sequence peptides to synthetic analogues with structural modifications. Gonadorelin represents the native sequence decapeptide, featuring a rapid receptor dissociation rate and a short half-life in aqueous media, making it ideal for transient activation experiments.
In contrast, synthetic GnRH agonists such as Triptorelin incorporate D-amino acid substitutions (e.g., D-Tryptophan at position 6) that dramatically increase enzymatic resistance and receptor binding affinity. Similarly, upstream neuroendocrine regulators like Kisspeptin-10 act higher in the signaling cascade, stimulating endogenous GnRH release from hypothalamic neurons rather than acting directly on pituitary GnRH receptors. Evaluating these distinct pharmacological profiles allows research teams to select the precise peptide ligand required for their target cellular pathways.
In vitro data indicate that synthetic Gonadorelin is widely employed to analyze GPCR trafficking, beta-arrestin recruitment, and downstream MAPK/ERK activation in immortalized pituitary cell lines such as LβT2 and αT3-1. These cellular models allow researchers to measure real-time intracellular calcium fluxes using fluorescent indicators when challenged with varying nanomolar concentrations of Gonadorelin.
In rodent models, research demonstrates that Gonadorelin administration provides a standardized method for assessing pituitary responsiveness. Experimental models investigating stress-induced HPG axis suppression, environmental endocrine disruptors, or metabolic impacts on reproductive neurobiology utilize Gonadorelin to bypass hypothalamic control and isolate anterior pituitary function. Maintaining precise molarity and freedom from cellular toxins is necessary to avoid confounding experimental outcomes in these sensitive preclinical models.
To ensure that experimental results reflect genuine peptide activity rather than artifacts caused by impurities, sourcing laboratory reagents requires strict analytical validation. At PX1 Research, every batch of Gonadorelin offered for sale undergoes thorough quality control in compliance with ISO 17025 standards.
Purity is assessed via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) using a C18 stationary phase and a gradient mobile phase (water/acetonitrile with 0.1% trifluoroacetic acid). This process verifies that total chromatographic purity exceeds 99%, isolating the target decapeptide from truncated sequences or synthesis side-products. Concurrently, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass (1182.3 Da), guaranteeing sequence accuracy before product release.
Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from Gram-negative outer membranes—represent a major source of error in cell culture and animal research. High endotoxin levels induce non-specific inflammatory signaling, alter cytokine profiles, and cause premature cell death in primary gonadotrope cultures.
PX1 Research conducts quantitative Limulus Amebocyte Lysate (LAL) testing on every lot of Gonadorelin to verify endotoxin levels remain strictly below <0.01 EU/mg. Combined with sterile, aseptic lyophylization protocols in GMP-compliant facilities, our analytical workflow ensures that researchers receive clean, uncompromised material ready for delicate biological assays.
Proper handling and preparation of lyophilized peptides are crucial for maintaining structural stability and preventing aggregation. Gonadorelin is supplied as a sterile, lyophilized white powder that must be reconstituted using appropriate laboratory solvents under laminar flow bio-safety cabinets.
For most in vitro assays, investigators reconstitute the lyophilisate using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4). To prevent shear stress and peptide denaturation, solvent should be allowed to run gently down the inner glass wall of the vial, followed by gentle swirling rather than vigorous vortexing. Detailed reconstitution protocols and concentration calculators can be referenced in our peptide reconstitution guide.
Lyophilized Gonadorelin demonstrates excellent long-term stability when stored at -20°C to -80°C in a desiccated environment away from light exposure. Under these conditions, the un-reconstituted peptide retains structural integrity for up to 24 months from the date of manufacture.
Once reconstituted into aqueous solution, Gonadorelin should be aliquoted into single-use polypropylene tubes to prevent repeated freeze-thaw cycles, which induce peptide degradation via surface adsorption and ice crystal formation. Reconstituted aliquots stored at -20°C remain stable for 30 to 90 days. PX1 Research ships all compounds directly from our state-of-the-art dispatch facilities in California and Arizona, utilizing temperature-monitored packaging to protect product integrity during transit.
University laboratories, contract research organizations (CROs), and biotechnology firms require consistent, large-scale supply chains to support multi-phase experimental trials. Inconsistent peptide purity across experimental phases introduces undesirable variables that can invalidate months of academic work.
PX1 Research supports institutional procurement by offering bulk lot reservations, custom packaging configurations, and dedicated analytical support. Laboratories requiring bulk quantities of Gonadorelin or establishing recurring supply agreements can register through our wholesale program to access dedicated account management, bulk pricing tiers, and prioritized lot reservations.
What is the purity level of Gonadorelin supplied by PX1 Research?
PX1 Research supplies Gonadorelin with a guaranteed chemical purity of >99% as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and verified by mass spectrometry.
How is Gonadorelin packaged and shipped for laboratory delivery?
Gonadorelin is supplied as a lyophilized (freeze-dried) powder sealed in vacuum-capped glass vials. It ships directly from our facilities in California and Arizona using protective, temperature-controlled packaging with standard same-day fulfillment on business days.
Where can I find the Certificate of Analysis (COA) for my Gonadorelin lot?
Every product shipped by PX1 Research includes a QR code and lot number linking directly to its lot-specific Certificate of Analysis. The COA details the RP-HPLC chromatogram, mass spectrometry identity confirmation, and endotoxin assay results.
What is the recommended storage procedure for lyophilized Gonadorelin?
Lyophilized Gonadorelin should be stored upon arrival at -20°C or -80°C in a dry, dark location. Stored at sub-zero temperatures, the un-reconstituted powder maintains full stability for up to 24 months.
What solvent should be used to reconstitute Gonadorelin for bench experiments?
Depending on the experimental design, researchers typically reconstitute Gonadorelin using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Solvents should be added gently down the vial wall to minimize bubble formation.
How does Gonadorelin differ from long-acting GnRH agonists like Triptorelin?
Gonadorelin possesses the exact primary sequence of native GnRH, leading to rapid receptor binding and quick dissociation. Analogues like Triptorelin feature D-amino acid modifications designed to increase enzymatic stability and binding duration, causing faster pituitary receptor desensitization.
What are the endotoxin limits for PX1 Research peptides?
PX1 Research enforces strict bioburden controls, guaranteeing that endotoxin levels in our research peptides measure below <0.01 EU/mg as validated by Limulus Amebocyte Lysate (LAL) testing.
Can Gonadorelin be purchased for clinical or personal use?
No. All products sold by PX1 Research, including Gonadorelin, are strictly intended for laboratory research use only. They are not intended for human consumption, clinical diagnosis, or veterinary therapeutic application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.